Astellas to acquire Ocata Therapeutics for $379 million
10 November 2015 | By Victoria White
Acquiring Ocata will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy...
List view / Grid view
10 November 2015 | By Victoria White
Acquiring Ocata will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy...
25 June 2015 | By
Results of four trials provide additional evidence supporting the safety and tolerability of hESC-derived retinal pigment epithelium...